Literature DB >> 26869270

[Depression in old age, part 2 : Comorbidity and treatment].

Dirk K Wolter1.   

Abstract

Depression in later life unfavorably impacts on the prognosis of comorbid somatic medical conditions. There are mutually reciprocal risk relationships with several frequently occurring medical conditions, such as diabetes, ischemic heart disease, stroke and Parkinson's disease. A wide range of psychological and psychosocial interventions, drug treatment and other biological interventions are available for treatment, including special interventions for enhancement of effectiveness and therapy resistance.

Entities:  

Keywords:  Antidepressants; Augmentation; Electroconvulsive therapy; Psychotherapy; Sleep deprivation

Mesh:

Substances:

Year:  2016        PMID: 26869270     DOI: 10.1007/s00391-016-1022-4

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  87 in total

Review 1.  Moderators of the relationship between depression and cardiovascular disorders: a systematic review.

Authors:  Bernhard T Baune; Michael Stuart; Ashley Gilmour; Heike Wersching; Volker Arolt; Klaus Berger
Journal:  Gen Hosp Psychiatry       Date:  2012-07-06       Impact factor: 3.238

2.  Pet therapy in elderly patients with mental illness.

Authors:  Francesca Moretti; Diana De Ronchi; Virginia Bernabei; Lucia Marchetti; Barbara Ferrari; Claudia Forlani; Francesca Negretti; Cleta Sacchetti; Anna Rita Atti
Journal:  Psychogeriatrics       Date:  2010-09-14       Impact factor: 2.440

Review 3.  Depression following myocardial infarction--an overseen complication with prognostic importance.

Authors:  Karen Kjær Larsen
Journal:  Dan Med J       Date:  2013-08       Impact factor: 1.240

4.  [Dementia and depression determine care dependency in Parkinson's disease: analysis of 1,449 outpatients receiving nursing care in Germany].

Authors:  O Riedel; R Dodel; G Deuschl; H Förstl; F Henn; I Heuser; W Oertel; H Reichmann; P Riederer; C Trenkwalder; H U Wittchen
Journal:  Nervenarzt       Date:  2011-08       Impact factor: 1.214

Review 5.  Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies.

Authors:  Suetonia Palmer; Mariacristina Vecchio; Jonathan C Craig; Marcello Tonelli; David W Johnson; Antonio Nicolucci; Fabio Pellegrini; Valeria Saglimbene; Giancarlo Logroscino; Steven Fishbane; Giovanni F M Strippoli
Journal:  Kidney Int       Date:  2013-03-13       Impact factor: 10.612

6.  [Psychotherapy of depression in old age].

Authors:  C Wächtler
Journal:  Z Gerontol Geriatr       Date:  2013-02       Impact factor: 1.281

7.  Major life events and development of major depression in Parkinson's disease patients.

Authors:  N H Rod; Y Bordelon; A Thompson; E Marcotte; B Ritz
Journal:  Eur J Neurol       Date:  2012-10-30       Impact factor: 6.089

Review 8.  Depression in type 2 diabetes mellitus--a brief review.

Authors:  Samreen Siddiqui
Journal:  Diabetes Metab Syndr       Date:  2013-07-30

Review 9.  Association between depression and mortality in patients receiving long-term dialysis: a systematic review and meta-analysis.

Authors:  Farhat Farrokhi; Neda Abedi; Joseph Beyene; Paul Kurdyak; Sarbjit Vanita Jassal
Journal:  Am J Kidney Dis       Date:  2013-11-01       Impact factor: 8.860

Review 10.  Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis.

Authors:  Fleur E P van Dooren; Giesje Nefs; Miranda T Schram; Frans R J Verhey; Johan Denollet; François Pouwer
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more
  2 in total

Review 1.  [Multiprofessional outpatient psychosocial treatment for elderly patients with mental disorders].

Authors:  L P Hölzel; M Härter; M Hüll
Journal:  Nervenarzt       Date:  2017-11       Impact factor: 1.214

Review 2.  [Diagnostics and multimodal treatment of depression in old age : New developments].

Authors:  Gerhard W Eschweiler
Journal:  Z Gerontol Geriatr       Date:  2017-01-19       Impact factor: 1.281

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.